Edison MSB research report 7 June 2017
http://www.edisoninvestmentresearch.com/research/report/mesoblast15/preview/
Phase III HF trial end has potentially slipped by 12 months.
An NIH-funded 159-patient Phase IIb in end-stage HF is expected to be fully enrolled soon and the NIH may report data in Q417.
Kentgrove facility a real possibility.
Keeping an eye on MSB. Not time to buy back in yet.
GLTAH DYOR
Edison MSB research report 7 June 2017...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |